Actuate Therapeutics raises ~$4.7M in private placement of common stock and warrants

ACTUATE THERAPEUTICS, INC.

Gross proceeds of approx. $4.7M from sale of 666,497 shares at $7.00/share and warrants to purchase 666,497 shares.
Warrants exercisable at $7.00 for 20 days after Milestone Date (FDA Breakthrough Therapy or registration determination for elraglusib).
Bios 2024 Co-Invest, LP (affiliated with Chairman Dr. Aaron G.L. Fletcher) purchasing 71,428 shares and warrants for ~$500K.
Closing expected on or before June 30, 2025; proceeds for working capital and general corporate purposes.
Registration rights agreement requires filing resale registration statement by August 9, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.